慢性全闭性穿皮冠状动脉干预:2026年更新
Semih Ceylan1, Deniz Mutlu2, Eleni Kladou3
1Bahcesehir University School of Medicine, Istanbul, Turkey.
The Journal of invasive cardiology
|February 19, 2026
概括
慢性全闭性冠状动脉透皮干预 (CTO PCI) 在专家中心显示超过90%的成功率,症状和辐射暴露减少. 新技术和人工智能正在提高结果.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医疗技术 医疗技术 医学技术
背景情况:
- 慢性全封闭 (CTO) 穿皮冠状动脉干预 (PCI) 是一种复杂的程序,具有不断发展的策略.
- 最近成像,设备和技术的进步正在改善CTO PCI结果.
- 了解最新的发展对于干预性心脏病学家来说至关重要.
研究的目的:
- 审查和总结关于CTO PCI的最新出版文献.
- 根据程序结果,技术和并发症对最近的进展进行分类.
- 突出正在进行的研究,塑造CTO PCI的未来.
主要方法:
- 从2023年9月到2025年4月,对CTO PCI发表的文献进行系统审查.
- 基于程序成功,新技术,并发症和新兴研究的发现的分类.
- 分析多中心数据和正在进行的随机试验.
主要成果:
- 在专家中心报告的技术成功率超过90%.
- 在CTO PCI后长期显著减少心痛和呼吸障碍.
- 由于设备升级和操作员意识,辐射暴露的减少.
- 通过冠状动脉CT指导,血管内超声波,水力动力学再通道化,逆行方法和AI工具等技术提高了成功和安全.
结论:
- CTO PCI正在快速发展,提供高成功率和改善患者的治疗结果.
- 技术创新和精细技术是CTO PCI进步的关键驱动力.
- 目前正在进行的研究和大型注册表将进一步完善CTO PCI战略和实践模式.
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
388
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
388
01:27Coronary Artery Disease V: Interprofessional Care
320
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
320
01:28Acute Coronary Syndrome IV: Interprofessional Care
315
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
315
01:30Acute Coronary Syndrome III: Diagnostic Studies
312
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
312
01:23Peripheral Artery Disease V: Postoperative Nursing Management
431
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
431
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
487
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
487